ARTICLEManagement of Antipsychotic-Induced Weight Gain: Part IRado, Jeffrey T. MDSection Editor(s): Janicak, Philip G. MD; Editor Author Information Dr. Rado is Assistant Professor of Psychiatry and Internal Medicine, Rush University Medical Center, 2150 West Harrison, Chicago, IL 60612; E-mail: email@example.com. All faculty and staff in a position to control the content of this CME activity, and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations related to this CME activity. The U.S. Food and Drug Administration has not approved the use of pharmacologic agents for the prevention or treatment of antipsychotic-induced weight gain as discussed in this article. Please consult the product's labeling for approved information. Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on May 31, 2014. Psychopharm Review: June 2013 - Volume 48 - Issue 6 - p 41-47 doi: 10.1097/01.PSYPHR.0000431724.27000.31 Buy Take the CME Test Metrics © 2013 Lippincott Williams & Wilkins, Inc.